Bright Green Corporation (BGXX)
USD 0.04
(0.0%)
USD 0.04
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -13.12 Million USD | 53.26% |
| 2022 | -28.08 Million USD | -1027.81% |
| 2021 | -2.49 Million USD | 21.1% |
| 2020 | -3.15 Million USD | -262.64% |
| 2019 | -870.46 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -1.44 Million USD | -52.06% |
| 2024 Q1 | -949.45 Thousand USD | 82.83% |
| 2023 Q3 | -1.99 Million USD | 33.45% |
| 2023 FY | -13.12 Million USD | 53.26% |
| 2023 Q4 | -5.53 Million USD | -177.76% |
| 2023 Q1 | -2.61 Million USD | -19.35% |
| 2023 Q2 | -2.99 Million USD | -14.44% |
| 2022 Q2 | -12.88 Million USD | -1673.69% |
| 2022 Q1 | -726.34 Thousand USD | 21.16% |
| 2022 FY | -28.08 Million USD | -1027.81% |
| 2022 Q4 | -2.19 Million USD | 62.08% |
| 2022 Q3 | -5.77 Million USD | 55.16% |
| 2021 Q4 | -921.29 Thousand USD | -46.65% |
| 2021 FY | -2.49 Million USD | 21.1% |
| 2021 Q3 | -628.21 Thousand USD | -45.6% |
| 2021 Q2 | -431.47 Thousand USD | 15.32% |
| 2021 Q1 | -509.54 Thousand USD | 26.57% |
| 2020 FY | -3.15 Million USD | -262.64% |
| 2020 Q4 | -693.93 Thousand USD | 43.7% |
| 2020 Q3 | -1.23 Million USD | -50.19% |
| 2020 Q2 | -820.63 Thousand USD | -45.72% |
| 2020 Q1 | -563.15 Thousand USD | 0.0% |
| 2019 FY | -870.46 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| BioQuest Corp. | -123.33 USD | -10644226.603% |
| Clever Leaves Holdings Inc. | -17.89 Million USD | 26.657% |
| Eagle Pharmaceuticals, Inc. | 35.64 Million USD | 136.832% |
| Guardion Health Sciences, Inc. | 158.03 Thousand USD | 8406.903% |
| GSRX Industries Inc. | - USD | Infinity% |
| High Sierra Technologies, Inc. | -323.95 Thousand USD | -3952.344% |
| Instadose Pharma Corp. | - USD | Infinity% |